Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.88955372 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.13740147 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.13740147 |
4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.77305187 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.58809044 |
6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.41304333 |
7 | negative regulation of cell killing (GO:0031342) | 5.41304333 |
8 | regulation of gamma-delta T cell activation (GO:0046643) | 5.32815343 |
9 | positive thymic T cell selection (GO:0045059) | 5.26721965 |
10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.12162188 |
11 | negative T cell selection (GO:0043383) | 5.05178199 |
12 | negative thymic T cell selection (GO:0045060) | 5.04068469 |
13 | detection of other organism (GO:0098543) | 4.68365627 |
14 | detection of bacterium (GO:0016045) | 4.59934600 |
15 | thymic T cell selection (GO:0045061) | 4.59420930 |
16 | response to interleukin-15 (GO:0070672) | 4.57733186 |
17 | positive T cell selection (GO:0043368) | 4.52338576 |
18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.47662653 |
19 | positive regulation of B cell differentiation (GO:0045579) | 4.44426346 |
20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.41688682 |
21 | T cell selection (GO:0045058) | 4.38616197 |
22 | interferon-gamma production (GO:0032609) | 4.26329956 |
23 | neutrophil activation involved in immune response (GO:0002283) | 4.26227103 |
24 | macrophage activation involved in immune response (GO:0002281) | 4.22633072 |
25 | leukocyte aggregation (GO:0070486) | 4.20264465 |
26 | * B cell receptor signaling pathway (GO:0050853) | 4.18845543 |
27 | regulation of B cell differentiation (GO:0045577) | 4.12035759 |
28 | response to peptidoglycan (GO:0032494) | 3.98804601 |
29 | cellular response to interleukin-15 (GO:0071350) | 3.96482961 |
30 | tolerance induction (GO:0002507) | 3.95297754 |
31 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.92854513 |
32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.90939963 |
33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.86154495 |
34 | detection of external biotic stimulus (GO:0098581) | 3.84359461 |
35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.79734304 |
36 | * T cell migration (GO:0072678) | 3.79488902 |
37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.77829685 |
38 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.64700470 |
39 | response to host immune response (GO:0052572) | 3.64700470 |
40 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.62572323 |
41 | response to muramyl dipeptide (GO:0032495) | 3.60581349 |
42 | neutrophil activation (GO:0042119) | 3.60214488 |
43 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.58978348 |
44 | negative regulation of phagocytosis (GO:0050765) | 3.56483934 |
45 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.55269606 |
46 | regulation of T cell tolerance induction (GO:0002664) | 3.54841021 |
47 | T cell homeostasis (GO:0043029) | 3.54506748 |
48 | * T cell receptor signaling pathway (GO:0050852) | 3.52875053 |
49 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.45327480 |
50 | positive regulation of interleukin-2 production (GO:0032743) | 3.45230664 |
51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42992537 |
52 | T cell costimulation (GO:0031295) | 3.42018089 |
53 | detection of molecule of bacterial origin (GO:0032490) | 3.41461626 |
54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.40231108 |
55 | response to host (GO:0075136) | 3.40231108 |
56 | response to host defenses (GO:0052200) | 3.40231108 |
57 | regulation of regulatory T cell differentiation (GO:0045589) | 3.36512369 |
58 | detection of biotic stimulus (GO:0009595) | 3.35961650 |
59 | lymphocyte costimulation (GO:0031294) | 3.35857402 |
60 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.30867609 |
61 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.29380573 |
62 | microglial cell activation (GO:0001774) | 3.28557328 |
63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.27306017 |
64 | defense response to protozoan (GO:0042832) | 3.25581218 |
65 | positive regulation of granulocyte differentiation (GO:0030854) | 3.25552265 |
66 | granulocyte activation (GO:0036230) | 3.25056167 |
67 | NIK/NF-kappaB signaling (GO:0038061) | 3.23156794 |
68 | immunoglobulin mediated immune response (GO:0016064) | 3.22304430 |
69 | regulation of mast cell degranulation (GO:0043304) | 3.19779660 |
70 | * myeloid cell activation involved in immune response (GO:0002275) | 3.19402451 |
71 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.18423450 |
72 | * respiratory burst (GO:0045730) | 3.18209090 |
73 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.18023369 |
74 | positive regulation of isotype switching (GO:0045830) | 3.17651330 |
75 | germinal center formation (GO:0002467) | 3.17637603 |
76 | negative regulation of innate immune response (GO:0045824) | 3.16939870 |
77 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.14197849 |
78 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.10500367 |
79 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.10092260 |
80 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.10092260 |
81 | myeloid dendritic cell activation (GO:0001773) | 3.09774017 |
82 | regulation of response to interferon-gamma (GO:0060330) | 3.07518993 |
83 | positive regulation of humoral immune response (GO:0002922) | 3.07351206 |
84 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07132079 |
85 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.05921216 |
86 | neutrophil mediated immunity (GO:0002446) | 3.05764104 |
87 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.04438193 |
88 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.04181999 |
89 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.02647515 |
90 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.02344421 |
91 | leukocyte cell-cell adhesion (GO:0007159) | 3.02321365 |
92 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.01921535 |
93 | positive regulation of histone deacetylation (GO:0031065) | 3.01199438 |
94 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.98365051 |
95 | macrophage activation (GO:0042116) | 2.98298504 |
96 | regulation of hypersensitivity (GO:0002883) | 2.97665712 |
97 | activated T cell proliferation (GO:0050798) | 2.96718415 |
98 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.96157058 |
99 | * cellular extravasation (GO:0045123) | 2.94221933 |
100 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.93778613 |
101 | positive regulation of tolerance induction (GO:0002645) | 2.93450229 |
102 | * lymphocyte homeostasis (GO:0002260) | 2.93233051 |
103 | positive regulation of mast cell activation (GO:0033005) | 2.92791456 |
104 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91952892 |
105 | * mast cell activation (GO:0045576) | 2.88084079 |
106 | mature B cell differentiation (GO:0002335) | 2.86032087 |
107 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.85228114 |
108 | regulation of granulocyte differentiation (GO:0030852) | 2.83897634 |
109 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.82495951 |
110 | myeloid dendritic cell differentiation (GO:0043011) | 2.81735701 |
111 | negative regulation of T cell mediated immunity (GO:0002710) | 2.81202704 |
112 | response to type I interferon (GO:0034340) | 2.80584280 |
113 | T cell proliferation (GO:0042098) | 2.79750484 |
114 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79586770 |
115 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77368353 |
116 | regulation of tolerance induction (GO:0002643) | 2.76106461 |
117 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.75740621 |
118 | positive regulation of B cell mediated immunity (GO:0002714) | 2.75740621 |
119 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.74225168 |
120 | type I interferon signaling pathway (GO:0060337) | 2.74011894 |
121 | cellular response to type I interferon (GO:0071357) | 2.74011894 |
122 | response to protozoan (GO:0001562) | 2.73612914 |
123 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.73034219 |
124 | modulation by symbiont of host immune response (GO:0052553) | 2.73034219 |
125 | positive regulation by symbiont of host defense response (GO:0052509) | 2.73034219 |
126 | modulation by symbiont of host defense response (GO:0052031) | 2.73034219 |
127 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.73034219 |
128 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.73034219 |
129 | negative regulation of interleukin-12 production (GO:0032695) | 2.71661351 |
130 | positive regulation of immunoglobulin production (GO:0002639) | 2.68479727 |
131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.68424683 |
132 | regulation of interleukin-2 production (GO:0032663) | 2.68283353 |
133 | positive regulation of T cell differentiation (GO:0045582) | 2.68090626 |
134 | positive regulation of B cell activation (GO:0050871) | 2.67766321 |
135 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.67328189 |
136 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.67328189 |
137 | positive regulation of DNA recombination (GO:0045911) | 2.66219979 |
138 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.63751452 |
139 | * natural killer cell activation (GO:0030101) | 2.61737504 |
140 | B cell mediated immunity (GO:0019724) | 2.61720847 |
141 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.61638879 |
142 | regulation of B cell mediated immunity (GO:0002712) | 2.61286535 |
143 | regulation of alpha-beta T cell activation (GO:0046634) | 2.59537401 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.24443978 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.80553371 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.57018104 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 4.23126672 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.95513438 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.39510696 |
7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34032269 |
8 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.08219458 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.07095353 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.04687442 |
11 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.97629216 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.88858914 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.85180148 |
14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.84768893 |
15 | MYB_26560356_Chip-Seq_TH2_Human | 2.84563400 |
16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.71901684 |
17 | * MAF_26560356_Chip-Seq_TH1_Human | 2.69094152 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.63593913 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.63308834 |
20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.55953549 |
21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.55060035 |
22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.52321824 |
23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.52174503 |
24 | * MYB_26560356_Chip-Seq_TH1_Human | 2.50910415 |
25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43808960 |
26 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.41275530 |
27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.38844392 |
28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.35968821 |
29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31596925 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28860482 |
31 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.27881179 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.22430850 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13390722 |
34 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10707307 |
35 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.10021964 |
36 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.05406153 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99963659 |
38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95950379 |
39 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.85139635 |
40 | * MAF_26560356_Chip-Seq_TH2_Human | 1.81024582 |
41 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.79916703 |
42 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69518783 |
43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.68822262 |
44 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.67149532 |
45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66034375 |
46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64687457 |
47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.63747978 |
48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61438240 |
49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60010460 |
50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56707053 |
51 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54774857 |
52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52841920 |
53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49975928 |
54 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.49831049 |
55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42383384 |
56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42068005 |
57 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39063104 |
58 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38844588 |
59 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32060266 |
60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30204734 |
61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29681182 |
62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26730760 |
63 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.26514823 |
64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26008497 |
65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23840239 |
66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23620000 |
67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23060399 |
68 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22161922 |
69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21666388 |
70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18828271 |
71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15896562 |
72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15205287 |
73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15065973 |
74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13644265 |
75 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12801178 |
76 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08946812 |
77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08203816 |
78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06605016 |
79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05508820 |
80 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.05273689 |
81 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04993107 |
82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04774445 |
83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03481378 |
84 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.03389106 |
85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02156854 |
86 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01731995 |
87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00955165 |
88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00092313 |
89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97299920 |
90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94889478 |
91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93184900 |
92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92473587 |
93 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.90372489 |
94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89011387 |
95 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88720060 |
96 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88643610 |
97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88048106 |
98 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86502818 |
99 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.85750198 |
100 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83980587 |
101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83086491 |
102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82220738 |
103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81757866 |
104 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.81411685 |
105 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81204669 |
106 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.80387364 |
107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76037236 |
108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74332642 |
109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73039329 |
110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71666284 |
111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.69610436 |
112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69348391 |
113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68765562 |
114 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.68419837 |
115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67616314 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 3.80090335 |
2 | MP0001835_abnormal_antigen_presentation | 3.74845163 |
3 | MP0000685_abnormal_immune_system | 3.54013170 |
4 | * MP0001800_abnormal_humoral_immune | 3.45854167 |
5 | MP0005671_abnormal_response_to | 3.35402815 |
6 | MP0001790_abnormal_immune_system | 3.22491283 |
7 | MP0005387_immune_system_phenotype | 3.22491283 |
8 | MP0002396_abnormal_hematopoietic_system | 2.95113561 |
9 | MP0003303_peritoneal_inflammation | 2.90370762 |
10 | * MP0002452_abnormal_antigen_presenting | 2.90165000 |
11 | * MP0002398_abnormal_bone_marrow | 2.85143566 |
12 | * MP0002420_abnormal_adaptive_immunity | 2.83162028 |
13 | * MP0005000_abnormal_immune_tolerance | 2.82717904 |
14 | * MP0002723_abnormal_immune_serum | 2.81155402 |
15 | * MP0001819_abnormal_immune_cell | 2.80045760 |
16 | MP0009785_altered_susceptibility_to | 2.51774130 |
17 | * MP0000716_abnormal_immune_system | 2.46697790 |
18 | * MP0003436_decreased_susceptibility_to | 2.45255296 |
19 | MP0005025_abnormal_response_to | 2.43297021 |
20 | MP0004808_abnormal_hematopoietic_stem | 2.40335409 |
21 | * MP0000689_abnormal_spleen_morphology | 2.33404700 |
22 | MP0002405_respiratory_system_inflammati | 2.33206914 |
23 | MP0003300_gastrointestinal_ulcer | 2.32708696 |
24 | * MP0002722_abnormal_immune_system | 2.29482024 |
25 | * MP0000703_abnormal_thymus_morphology | 2.25830948 |
26 | * MP0002419_abnormal_innate_immunity | 2.19788018 |
27 | MP0009333_abnormal_splenocyte_physiolog | 2.18907658 |
28 | MP0002166_altered_tumor_susceptibility | 2.16418493 |
29 | MP0002148_abnormal_hypersensitivity_rea | 2.10474952 |
30 | * MP0002429_abnormal_blood_cell | 2.07127977 |
31 | MP0001873_stomach_inflammation | 2.06201794 |
32 | * MP0005464_abnormal_platelet_physiology | 1.97709659 |
33 | * MP0010155_abnormal_intestine_physiology | 1.95002736 |
34 | MP0006082_CNS_inflammation | 1.90046953 |
35 | MP0004510_myositis | 1.88207847 |
36 | MP0003866_abnormal_defecation | 1.87277870 |
37 | MP0004947_skin_inflammation | 1.84176306 |
38 | MP0002006_tumorigenesis | 1.81052320 |
39 | MP0009278_abnormal_bone_marrow | 1.78403847 |
40 | MP0008260_abnormal_autophagy | 1.72215125 |
41 | * MP0001845_abnormal_inflammatory_respons | 1.70881311 |
42 | MP0001545_abnormal_hematopoietic_system | 1.68368300 |
43 | MP0005397_hematopoietic_system_phenotyp | 1.68368300 |
44 | MP0004381_abnormal_hair_follicle | 1.65380809 |
45 | MP0000465_gastrointestinal_hemorrhage | 1.65054353 |
46 | MP0003724_increased_susceptibility_to | 1.59383914 |
47 | MP0001853_heart_inflammation | 1.51836391 |
48 | MP0005310_abnormal_salivary_gland | 1.51396700 |
49 | MP0003077_abnormal_cell_cycle | 1.32068195 |
50 | MP0002933_joint_inflammation | 1.28368184 |
51 | MP0010094_abnormal_chromosome_stability | 1.27077785 |
52 | MP0010352_gastrointestinal_tract_polyps | 1.26576338 |
53 | * MP0000490_abnormal_crypts_of | 1.26363201 |
54 | MP0008057_abnormal_DNA_replication | 1.26028267 |
55 | MP0002019_abnormal_tumor_incidence | 1.25653159 |
56 | MP0010307_abnormal_tumor_latency | 1.24551980 |
57 | MP0000858_altered_metastatic_potential | 1.19733830 |
58 | MP0003693_abnormal_embryo_hatching | 1.18857250 |
59 | MP0004883_abnormal_blood_vessel | 1.14310623 |
60 | MP0005174_abnormal_tail_pigmentation | 1.13904563 |
61 | MP0002277_abnormal_respiratory_mucosa | 1.11944448 |
62 | MP0008469_abnormal_protein_level | 1.10368452 |
63 | MP0003448_altered_tumor_morphology | 1.08367677 |
64 | * MP0001533_abnormal_skeleton_physiology | 1.06243444 |
65 | MP0005076_abnormal_cell_differentiation | 1.06240840 |
66 | MP0008961_abnormal_basal_metabolism | 1.05569173 |
67 | MP0001851_eye_inflammation | 1.04871682 |
68 | MP0003111_abnormal_nucleus_morphology | 1.03032513 |
69 | MP0002009_preneoplasia | 0.89792806 |
70 | MP0005058_abnormal_lysosome_morphology | 0.82271330 |
71 | MP0005075_abnormal_melanosome_morpholog | 0.81139406 |
72 | MP0003172_abnormal_lysosome_physiology | 0.80419017 |
73 | MP0003075_altered_response_to | 0.80252403 |
74 | MP0001986_abnormal_taste_sensitivity | 0.80040151 |
75 | MP0008007_abnormal_cellular_replicative | 0.76672590 |
76 | MP0005164_abnormal_response_to | 0.76670370 |
77 | MP0002132_abnormal_respiratory_system | 0.75916057 |
78 | MP0004957_abnormal_blastocyst_morpholog | 0.73646499 |
79 | MP0003045_fibrosis | 0.73443727 |
80 | MP0000313_abnormal_cell_death | 0.73341160 |
81 | MP0003690_abnormal_glial_cell | 0.71326892 |
82 | MP0002998_abnormal_bone_remodeling | 0.71025239 |
83 | MP0003656_abnormal_erythrocyte_physiolo | 0.71008145 |
84 | MP0003566_abnormal_cell_adhesion | 0.68667177 |
85 | MP0000350_abnormal_cell_proliferation | 0.68617223 |
86 | MP0005023_abnormal_wound_healing | 0.67990170 |
87 | MP0005166_decreased_susceptibility_to | 0.67012941 |
88 | MP0003191_abnormal_cellular_cholesterol | 0.66740218 |
89 | MP0008058_abnormal_DNA_repair | 0.66370633 |
90 | MP0000604_amyloidosis | 0.65705856 |
91 | * MP0005390_skeleton_phenotype | 0.65290393 |
92 | MP0003828_pulmonary_edema | 0.65196226 |
93 | MP0009763_increased_sensitivity_to | 0.64047033 |
94 | MP0009765_abnormal_xenobiotic_induced | 0.63436804 |
95 | MP0003795_abnormal_bone_structure | 0.60857173 |
96 | MP0001663_abnormal_digestive_system | 0.60690619 |
97 | MP0000569_abnormal_digit_pigmentation | 0.60370222 |
98 | MP0000015_abnormal_ear_pigmentation | 0.60249087 |
99 | MP0008877_abnormal_DNA_methylation | 0.60235583 |
100 | MP0003091_abnormal_cell_migration | 0.59922280 |
101 | MP0000249_abnormal_blood_vessel | 0.58757035 |
102 | MP0004130_abnormal_muscle_cell | 0.58483326 |
103 | MP0002138_abnormal_hepatobiliary_system | 0.57720524 |
104 | MP0008874_decreased_physiological_sensi | 0.55678510 |
105 | MP0002928_abnormal_bile_duct | 0.55341897 |
106 | MP0005451_abnormal_body_composition | 0.55289353 |
107 | MP0001730_embryonic_growth_arrest | 0.55100023 |
108 | MP0003787_abnormal_imprinting | 0.54899890 |
109 | MP0009840_abnormal_foam_cell | 0.54878837 |
110 | MP0002693_abnormal_pancreas_physiology | 0.54558276 |
111 | MP0008873_increased_physiological_sensi | 0.54350395 |
112 | MP0009764_decreased_sensitivity_to | 0.52661559 |
113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52598867 |
114 | MP0005621_abnormal_cell_physiology | 0.52116476 |
115 | MP0003183_abnormal_peptide_metabolism | 0.51768412 |
116 | MP0002095_abnormal_skin_pigmentation | 0.51031159 |
117 | MP0000343_altered_response_to | 0.50745740 |
118 | * MP0000477_abnormal_intestine_morphology | 0.50302887 |
119 | MP0004185_abnormal_adipocyte_glucose | 0.50074890 |
120 | MP0001348_abnormal_lacrimal_gland | 0.49866995 |
121 | MP0002136_abnormal_kidney_physiology | 0.49713918 |
122 | MP0008004_abnormal_stomach_pH | 0.49002896 |
123 | MP0000609_abnormal_liver_physiology | 0.44656784 |
124 | MP0005381_digestive/alimentary_phenotyp | 0.43933728 |
125 | MP0000371_diluted_coat_color | 0.43206547 |
126 | MP0009115_abnormal_fat_cell | 0.38534845 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Agammaglobulinemia (HP:0004432) | 4.93377802 |
2 | Chronic otitis media (HP:0000389) | 4.73403587 |
3 | IgM deficiency (HP:0002850) | 4.71638486 |
4 | Recurrent viral infections (HP:0004429) | 4.67718752 |
5 | Recurrent bronchitis (HP:0002837) | 4.61172098 |
6 | T lymphocytopenia (HP:0005403) | 4.49166897 |
7 | Panhypogammaglobulinemia (HP:0003139) | 4.42751413 |
8 | Recurrent fungal infections (HP:0002841) | 4.33375556 |
9 | Recurrent abscess formation (HP:0002722) | 4.30509997 |
10 | Abnormality of T cell number (HP:0011839) | 4.25618449 |
11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.19254474 |
12 | Gastrointestinal infarctions (HP:0005244) | 4.15147488 |
13 | Eczematoid dermatitis (HP:0000976) | 4.14660651 |
14 | * Cellulitis (HP:0100658) | 4.13701332 |
15 | Nasal polyposis (HP:0100582) | 4.09282246 |
16 | Recurrent bacterial skin infections (HP:0005406) | 3.97035429 |
17 | Abnormality of the fingertips (HP:0001211) | 3.96131958 |
18 | Meningitis (HP:0001287) | 3.93303898 |
19 | Verrucae (HP:0200043) | 3.92382110 |
20 | Papilloma (HP:0012740) | 3.92382110 |
21 | Abnormality of T cells (HP:0002843) | 3.80700210 |
22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.65331609 |
23 | Myositis (HP:0100614) | 3.60400504 |
24 | Pustule (HP:0200039) | 3.60195916 |
25 | Inflammation of the large intestine (HP:0002037) | 3.58502427 |
26 | Gastrointestinal inflammation (HP:0004386) | 3.57481868 |
27 | Abnormality of the nasal mucosa (HP:0000433) | 3.48621384 |
28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44015498 |
29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44015498 |
30 | Thyroiditis (HP:0100646) | 3.39447329 |
31 | Spontaneous hematomas (HP:0007420) | 3.36808576 |
32 | Colitis (HP:0002583) | 3.31769903 |
33 | Keratoconjunctivitis (HP:0001096) | 3.24409284 |
34 | Autoimmune thrombocytopenia (HP:0001973) | 3.24368879 |
35 | Urticaria (HP:0001025) | 3.22686782 |
36 | Lymphopenia (HP:0001888) | 3.14055472 |
37 | Abnormality of B cell number (HP:0010975) | 3.13785677 |
38 | B lymphocytopenia (HP:0010976) | 3.13785677 |
39 | Recurrent skin infections (HP:0001581) | 3.10158682 |
40 | Stomatitis (HP:0010280) | 3.06889372 |
41 | Abnormality of T cell physiology (HP:0011840) | 3.06690698 |
42 | Combined immunodeficiency (HP:0005387) | 3.04723653 |
43 | Severe combined immunodeficiency (HP:0004430) | 3.02719693 |
44 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.02400132 |
45 | Chronic sinusitis (HP:0011109) | 3.01333613 |
46 | Mediastinal lymphadenopathy (HP:0100721) | 3.00182635 |
47 | Hypochromic anemia (HP:0001931) | 2.97432250 |
48 | Thrombocytosis (HP:0001894) | 2.91672941 |
49 | Vasculitis (HP:0002633) | 2.91496592 |
50 | Obstructive lung disease (HP:0006536) | 2.89636230 |
51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89636230 |
52 | Osteomyelitis (HP:0002754) | 2.89164606 |
53 | Hypochromic microcytic anemia (HP:0004840) | 2.88007962 |
54 | Prolonged bleeding time (HP:0003010) | 2.87351567 |
55 | Increased IgM level (HP:0003496) | 2.80874368 |
56 | Increased IgE level (HP:0003212) | 2.80512039 |
57 | IgG deficiency (HP:0004315) | 2.77922263 |
58 | Recurrent sinusitis (HP:0011108) | 2.76844800 |
59 | Petechiae (HP:0000967) | 2.72044399 |
60 | Eosinophilia (HP:0001880) | 2.67117561 |
61 | Bronchitis (HP:0012387) | 2.66324467 |
62 | Episodic fever (HP:0001954) | 2.60381277 |
63 | Optic neuritis (HP:0100653) | 2.57660350 |
64 | Retrobulbar optic neuritis (HP:0100654) | 2.57660350 |
65 | Leukocytosis (HP:0001974) | 2.55791020 |
66 | Encephalitis (HP:0002383) | 2.55183720 |
67 | Abnormality of eosinophils (HP:0001879) | 2.53891406 |
68 | Anorexia (HP:0002039) | 2.53480289 |
69 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.46152456 |
70 | Increased density of long bones (HP:0006392) | 2.41701173 |
71 | IgA deficiency (HP:0002720) | 2.41451873 |
72 | Orchitis (HP:0100796) | 2.40773579 |
73 | Granulocytopenia (HP:0001913) | 2.38899710 |
74 | Sepsis (HP:0100806) | 2.35970320 |
75 | Abnormality of the pleura (HP:0002103) | 2.35481473 |
76 | Gastrointestinal stroma tumor (HP:0100723) | 2.34342425 |
77 | Viral hepatitis (HP:0006562) | 2.33400566 |
78 | Lymphoma (HP:0002665) | 2.33188587 |
79 | Epistaxis (HP:0000421) | 2.29264674 |
80 | Abnormal platelet volume (HP:0011876) | 2.29233159 |
81 | Microcytic anemia (HP:0001935) | 2.29101248 |
82 | Pulmonary infiltrates (HP:0002113) | 2.28031483 |
83 | Arterial thrombosis (HP:0004420) | 2.24818319 |
84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21713665 |
85 | Chronic diarrhea (HP:0002028) | 2.20605734 |
86 | Slow saccadic eye movements (HP:0000514) | 2.20306315 |
87 | Emphysema (HP:0002097) | 2.19849787 |
88 | Skin ulcer (HP:0200042) | 2.18809490 |
89 | Gangrene (HP:0100758) | 2.17859317 |
90 | Recurrent pneumonia (HP:0006532) | 2.17201752 |
91 | Hemoptysis (HP:0002105) | 2.17117451 |
92 | Recurrent otitis media (HP:0000403) | 2.17116613 |
93 | Basal cell carcinoma (HP:0002671) | 2.16502113 |
94 | Chest pain (HP:0100749) | 2.15767112 |
95 | Interstitial pulmonary disease (HP:0006530) | 2.15292431 |
96 | Periodontitis (HP:0000704) | 2.13199999 |
97 | Abnormality of macrophages (HP:0004311) | 2.09528889 |
98 | Peritonitis (HP:0002586) | 2.09422106 |
99 | Glomerulopathy (HP:0100820) | 2.08994228 |
100 | Abnormality of the peritoneum (HP:0002585) | 2.07928296 |
101 | Recurrent lower respiratory tract infections (HP:0002783) | 2.07257692 |
102 | Restrictive lung disease (HP:0002091) | 2.06954276 |
103 | Papilledema (HP:0001085) | 2.05040174 |
104 | Autoimmune hemolytic anemia (HP:0001890) | 2.04651413 |
105 | Impaired platelet aggregation (HP:0003540) | 2.03063860 |
106 | Abnormal platelet function (HP:0011869) | 2.03063860 |
107 | Acute hepatic failure (HP:0006554) | 2.01113927 |
108 | Gingival bleeding (HP:0000225) | 1.99615421 |
109 | Premature loss of primary teeth (HP:0006323) | 1.99449423 |
110 | Abnormality of the prostate (HP:0008775) | 1.96975911 |
111 | Abnormality of the endocardium (HP:0004306) | 1.94304384 |
112 | Keratitis (HP:0000491) | 1.93643098 |
113 | Gingivitis (HP:0000230) | 1.91524543 |
114 | Keratoconjunctivitis sicca (HP:0001097) | 1.89880110 |
115 | Acute myeloid leukemia (HP:0004808) | 1.88983867 |
116 | Purpura (HP:0000979) | 1.86851238 |
117 | Hematochezia (HP:0002573) | 1.85164691 |
118 | Fatigue (HP:0012378) | 1.84723240 |
119 | Abnormality of the intervertebral disk (HP:0005108) | 1.80096728 |
120 | Joint swelling (HP:0001386) | 1.79975705 |
121 | Skin rash (HP:0000988) | 1.78732593 |
122 | Cheilitis (HP:0100825) | 1.77567616 |
123 | Pulmonary embolism (HP:0002204) | 1.76528812 |
124 | Hypergammaglobulinemia (HP:0010702) | 1.75252014 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.55622015 |
2 | EEF2K | 4.77637927 |
3 | MAP3K10 | 3.65903901 |
4 | PRPF4B | 3.01626667 |
5 | TXK | 2.92243087 |
6 | STK10 | 2.66374242 |
7 | GRK6 | 2.52656114 |
8 | JAK3 | 2.52463197 |
9 | TYK2 | 2.47399467 |
10 | ZAP70 | 2.31959813 |
11 | ITK | 2.15253865 |
12 | BTK | 2.12500751 |
13 | BLK | 2.00955728 |
14 | SYK | 1.83776286 |
15 | IKBKE | 1.81167972 |
16 | PKN2 | 1.78324816 |
17 | FGFR4 | 1.72756306 |
18 | MAP3K14 | 1.70496601 |
19 | JAK1 | 1.69868848 |
20 | SIK2 | 1.64973991 |
21 | HCK | 1.60255718 |
22 | TBK1 | 1.50275343 |
23 | TRIB3 | 1.49104852 |
24 | TEC | 1.48875157 |
25 | LCK | 1.48135506 |
26 | CSF1R | 1.44720396 |
27 | FGFR3 | 1.43803253 |
28 | CLK1 | 1.43472920 |
29 | CDK12 | 1.41043813 |
30 | FES | 1.40464937 |
31 | NLK | 1.36796850 |
32 | RIPK4 | 1.36511339 |
33 | MAP3K13 | 1.35972074 |
34 | PIM1 | 1.34269726 |
35 | ERN1 | 1.29779026 |
36 | FGR | 1.29653751 |
37 | KIT | 1.29567639 |
38 | LRRK2 | 1.28726043 |
39 | SMG1 | 1.26269200 |
40 | MAP3K3 | 1.25814928 |
41 | CSK | 1.23271036 |
42 | IKBKB | 1.17186715 |
43 | TGFBR2 | 1.13871358 |
44 | MARK3 | 1.12546784 |
45 | IRAK4 | 1.10976718 |
46 | NEK2 | 1.10421587 |
47 | MAP3K1 | 1.05838828 |
48 | EPHB1 | 1.04580704 |
49 | LYN | 1.02466327 |
50 | KSR2 | 0.98722335 |
51 | CDK4 | 0.98081568 |
52 | TAOK3 | 0.97509587 |
53 | RPS6KA4 | 0.97170001 |
54 | YES1 | 0.91359509 |
55 | JAK2 | 0.90547711 |
56 | TNK2 | 0.86413025 |
57 | CHUK | 0.86356333 |
58 | PRKCH | 0.83790204 |
59 | BMPR2 | 0.83238903 |
60 | MAP2K3 | 0.81072788 |
61 | RPS6KB2 | 0.80096824 |
62 | STK4 | 0.77811209 |
63 | IRAK1 | 0.77070578 |
64 | CAMKK1 | 0.75958760 |
65 | TAOK1 | 0.72549006 |
66 | MATK | 0.71336291 |
67 | HIPK2 | 0.71260640 |
68 | TAOK2 | 0.71130196 |
69 | TRPM7 | 0.70268461 |
70 | CDC42BPA | 0.69696169 |
71 | PRKCQ | 0.67397819 |
72 | ALK | 0.66660977 |
73 | MAP3K7 | 0.66640150 |
74 | MAPK7 | 0.66022210 |
75 | CAMKK2 | 0.65566260 |
76 | CDC7 | 0.64519177 |
77 | CDK19 | 0.62433099 |
78 | MST4 | 0.61395959 |
79 | MAPK11 | 0.60664385 |
80 | FYN | 0.58230682 |
81 | SIK1 | 0.57693666 |
82 | PDPK1 | 0.56854244 |
83 | MAP3K8 | 0.55888595 |
84 | MELK | 0.55795939 |
85 | IRAK2 | 0.55079957 |
86 | PDK1 | 0.54208709 |
87 | CDK9 | 0.54108492 |
88 | MAPKAPK3 | 0.54085472 |
89 | NME2 | 0.53465832 |
90 | PRKD2 | 0.52605387 |
91 | PIK3CG | 0.52514819 |
92 | FLT3 | 0.52514633 |
93 | MAPK12 | 0.51446980 |
94 | MARK2 | 0.51280113 |
95 | TESK2 | 0.50847545 |
96 | IRAK3 | 0.49816011 |
97 | STK11 | 0.49414000 |
98 | EPHA3 | 0.49308320 |
99 | MAPK4 | 0.48947374 |
100 | NEK9 | 0.45609845 |
101 | CDK6 | 0.45571485 |
102 | RPS6KC1 | 0.45138578 |
103 | RPS6KL1 | 0.45138578 |
104 | STK24 | 0.44966236 |
105 | PTK2B | 0.44952031 |
106 | PTK6 | 0.43104526 |
107 | MAP3K6 | 0.42644128 |
108 | PASK | 0.41891686 |
109 | MAP2K2 | 0.41126779 |
110 | DMPK | 0.39748944 |
111 | TTN | 0.39486633 |
112 | SIK3 | 0.39185971 |
113 | DYRK1B | 0.38671402 |
114 | TGFBR1 | 0.37369276 |
115 | MAPKAPK2 | 0.37291073 |
116 | PDGFRB | 0.37280329 |
117 | MAP3K5 | 0.34487079 |
118 | BRD4 | 0.33612844 |
119 | SGK3 | 0.32532995 |
120 | RPS6KA6 | 0.31969389 |
121 | SGK2 | 0.31864580 |
122 | MAP3K2 | 0.31167375 |
123 | RAF1 | 0.30347284 |
124 | ATR | 0.30114583 |
125 | ABL1 | 0.29008839 |
126 | SCYL2 | 0.28532104 |
127 | MAP3K11 | 0.26208363 |
128 | RPS6KA1 | 0.24580507 |
129 | MAPK3 | 0.23086851 |
130 | RET | 0.22420815 |
131 | EGFR | 0.21966657 |
132 | RPS6KA5 | 0.21645151 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.61018819 |
2 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.96599402 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55205264 |
4 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.50465243 |
5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.42737831 |
6 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37596879 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36930848 |
8 | * Measles_Homo sapiens_hsa05162 | 2.32121486 |
9 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.31987623 |
10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.20875292 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17360224 |
12 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.91176468 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85352170 |
14 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79664044 |
15 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.70760950 |
16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69053262 |
17 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48101795 |
18 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47728890 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46257214 |
20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43513147 |
21 | * Hepatitis B_Homo sapiens_hsa05161 | 1.40523595 |
22 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39317179 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38090870 |
24 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.37736052 |
25 | Shigellosis_Homo sapiens_hsa05131 | 1.37244093 |
26 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37191868 |
27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32906310 |
28 | Allograft rejection_Homo sapiens_hsa05330 | 1.32831639 |
29 | * Influenza A_Homo sapiens_hsa05164 | 1.28554037 |
30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27276323 |
31 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24585079 |
32 | DNA replication_Homo sapiens_hsa03030 | 1.24136493 |
33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.23819384 |
34 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23116927 |
35 | Tuberculosis_Homo sapiens_hsa05152 | 1.22979580 |
36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19980910 |
37 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.19750865 |
38 | * Apoptosis_Homo sapiens_hsa04210 | 1.17788640 |
39 | * Platelet activation_Homo sapiens_hsa04611 | 1.17511970 |
40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10542562 |
41 | Phagosome_Homo sapiens_hsa04145 | 1.09723981 |
42 | Legionellosis_Homo sapiens_hsa05134 | 1.08927417 |
43 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.08510374 |
44 | Base excision repair_Homo sapiens_hsa03410 | 1.07837833 |
45 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.07244302 |
46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04426215 |
47 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04340129 |
48 | Pertussis_Homo sapiens_hsa05133 | 1.03297982 |
49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02559561 |
50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98765173 |
51 | Asthma_Homo sapiens_hsa05310 | 0.98154323 |
52 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.97507522 |
53 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94526365 |
54 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94444311 |
55 | Mismatch repair_Homo sapiens_hsa03430 | 0.91482675 |
56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90818065 |
57 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90518316 |
58 | Malaria_Homo sapiens_hsa05144 | 0.89824500 |
59 | * Colorectal cancer_Homo sapiens_hsa05210 | 0.88297948 |
60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87328406 |
61 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86813786 |
62 | Salmonella infection_Homo sapiens_hsa05132 | 0.86791452 |
63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82897179 |
64 | Cell cycle_Homo sapiens_hsa04110 | 0.82699643 |
65 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81107142 |
66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80949857 |
67 | Spliceosome_Homo sapiens_hsa03040 | 0.80232455 |
68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.77019068 |
69 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75694094 |
70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75516151 |
71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74149582 |
72 | * Hepatitis C_Homo sapiens_hsa05160 | 0.72851412 |
73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71319733 |
74 | RNA degradation_Homo sapiens_hsa03018 | 0.70008498 |
75 | Ribosome_Homo sapiens_hsa03010 | 0.68678011 |
76 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67596687 |
77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67091683 |
78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65767429 |
79 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65687740 |
80 | Endocytosis_Homo sapiens_hsa04144 | 0.64275607 |
81 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59503604 |
82 | Homologous recombination_Homo sapiens_hsa03440 | 0.58818230 |
83 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.58636311 |
84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58632298 |
85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57954246 |
86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57424718 |
87 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53542418 |
88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53239100 |
89 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52681437 |
90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52043309 |
91 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51638461 |
92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51453391 |
93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50421727 |
94 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49826191 |
95 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45564985 |
96 | RNA transport_Homo sapiens_hsa03013 | 0.45491300 |
97 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43169277 |
98 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42509575 |
99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42148916 |
100 | * Insulin resistance_Homo sapiens_hsa04931 | 0.41907089 |
101 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41008035 |
102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39908501 |
103 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39352652 |
104 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38130338 |
105 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37392713 |
106 | Lysine degradation_Homo sapiens_hsa00310 | 0.37287506 |
107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36432523 |
108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36177025 |
109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35381539 |
110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34363916 |
111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33811938 |
112 | * Prostate cancer_Homo sapiens_hsa05215 | 0.33295085 |
113 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32979205 |
114 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.32817454 |
115 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.32148884 |
116 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31986298 |
117 | Lysosome_Homo sapiens_hsa04142 | 0.30648423 |
118 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.29294382 |
119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28364017 |
120 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.25311073 |
121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.23088489 |